[go: up one dir, main page]

JPS6154450A - Gel for affinity chromatography having group specificity and its production - Google Patents

Gel for affinity chromatography having group specificity and its production

Info

Publication number
JPS6154450A
JPS6154450A JP59177347A JP17734784A JPS6154450A JP S6154450 A JPS6154450 A JP S6154450A JP 59177347 A JP59177347 A JP 59177347A JP 17734784 A JP17734784 A JP 17734784A JP S6154450 A JPS6154450 A JP S6154450A
Authority
JP
Japan
Prior art keywords
gel
cellulose
buffer
sulfuric acid
chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59177347A
Other languages
Japanese (ja)
Other versions
JPH0423751B2 (en
Inventor
Tetsuo Kawahara
川原 哲夫
Kyosuke Mizuno
水野 喬介
Sadao Shin
進 貞夫
Hiroshi Mizogami
寛 溝上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP59177347A priority Critical patent/JPS6154450A/en
Publication of JPS6154450A publication Critical patent/JPS6154450A/en
Publication of JPH0423751B2 publication Critical patent/JPH0423751B2/ja
Granted legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/291Gel sorbents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00Aspects relating to sorbent materials
    • B01J2220/50Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/54Sorbents specially adapted for analytical or investigative chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

PURPOSE:To obtain a gel for chromatography which maintains a solid granular state, is insoluble in an aq. solvent and has excellent physical stability by esterifying non-crosslinked cellulose by sulfuric acid. CONSTITUTION:A esterifying agent such as sulfuric acid is dissolved in amine or amide and the granular material of the non-crosslinked cellulose is brought into reaction therewith and is then neutralized with an alkali. Sulfuric anhydride or chlorosulfonic acid is preferable as the esterifying agent such as sulfuric acid and is used at about 1-50pts. (pts.wt., hereafter the same) in 100pts. the raw material cellulose and the reaction is effected at about -10-100 deg.C for about 30min-6hr. The amine or amide to be used as the solvent is exemplified by pyridine, dimethylformamide, etc. and the raw material cellulose to be added thereto so as to react therewith is used after the commercially marketed granular material having about 15-150mum grain size for chromatography is dried to about 1% moisture content. The resultant gel for affinity chromatography consists of the water-insoluble solid granular particles of the non-crosslinked cellulose sulfate having 15-150mum grain size.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、各種の蛋白質、ウィルスなどの精製に有用な
アフイニティクロマトグラフィ用ゲル、さらに詳しくは
、固体粒状非架橋セルロースの硫酸エステルゲルからな
る群特異性を有するアフィニテイクロマトグラフイ用ゲ
ルおよびその製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to affinity chromatography gels useful for the purification of various proteins, viruses, etc., and more specifically to a group consisting of solid granular non-crosslinked cellulose sulfate ester gels. The present invention relates to a gel for affinity chromatography having specificity and a method for producing the same.

従来技術 特定の蛋白質、ウィルスなどを精製取得するには、従来
、遠心分離法、イオン交換法、ケ゛ル濾過法などが採用
されており、これらの方法を適宜組合せたり、また反覆
して用いられる。ところで、これらの方法を組合せある
いは反覆して実施する場合、各工程ごとに複雑な操作を
必要とし、また長時間を要するうえ、それらの工程を経
るにしたがって目的物の損失減量が生じる不利益がある
Prior Art Conventionally, centrifugation, ion exchange, gel filtration, and the like have been used to purify and obtain specific proteins, viruses, etc., and these methods are appropriately combined or repeated. By the way, when these methods are combined or repeated, each step requires complicated operations, takes a long time, and has the disadvantage that the target material is lost and reduced as the steps go through. be.

別の精製法として、生物学的親和性を有する物質を用い
てクロマトグラフィにより生体物質を分離精製する、い
わゆるアフイニティクロマトグラフイ法も知られている
。そのような生物学的親和性を有する物質として強酸性
のムコ多糖類であるヘパリンがあり、これは生体内で種
々の重要な生理活性を有する蛋白質と結合する特性を有
し、例えばアンチトロンビンIII と結合して血液凝
固阻止作用を促進したり、リボ蛋白リパーゼと結合して
脂血清澄作用を示すなど重要な生理作用、薬理作用を示
す。
As another purification method, a so-called affinity chromatography method is also known, in which biological substances are separated and purified by chromatography using a substance that has biological affinity. Heparin, a strongly acidic mucopolysaccharide, is a substance with such biological affinity, and it has the property of binding to proteins that have various important physiological activities in vivo, such as antithrombin III. It exhibits important physiological and pharmacological effects, such as promoting blood coagulation prevention by binding to riboprotein lipase, and exhibiting lipid-serum clarifying effects by binding to riboprotein lipase.

かかるヘパリンの生理活性を利用して、これをセファ0
−スCL−4,8(ファルマシア社製)などのクロマト
グラフィ用ゲル担体にCNBrなどを用いて結合させて
アフィニティクロマトグラフィ用ゲルを調製し、それを
用いてアンチトロンビンIII 、凝固因子、リポ蛋白
リパーゼなどの重要な生理活性を有する蛋白質を精製す
ることが提案されている。しカルなが呟ヘパリンは動物
の肺臓、腎臓、肝臓などから抽出精製されるものである
ため、その操作が煩雑であり、しかも原料が違えばヘパ
リンの性状も異なるため、同一性状のヘパリンを大量に
入手することが困難でかつきわめて高価である。したが
って、ヘパリ、ンを結合させたアフィニティクロマトグ
ラフィ用ゲルを用いる方法は現段階では工業的規模で採
用することば外わめて難り化い。
Utilizing the physiological activity of heparin, it can be converted into Cepha-0.
A gel for affinity chromatography is prepared by binding to a chromatography gel carrier such as CL-4, 8 (manufactured by Pharmacia) using CNBr, etc., and using it, antithrombin III, coagulation factors, lipoprotein lipase, etc. It has been proposed to purify proteins with important physiological activities. Heparin is extracted and purified from animal lungs, kidneys, livers, etc., so the process is complicated, and different raw materials have different heparin properties, so it is necessary to produce large quantities of heparin with the same properties. It is difficult to obtain and extremely expensive. Therefore, the method of using affinity chromatography gel bound with heparin is currently extremely difficult to employ on an industrial scale.

1935年ジョルベスら(Jorpes et al)
によりヘパリンの血液凝固阻止作用は分子中の硫酸基の
存在に基づくことか明らかにされて以来、ヘパリンに代
る高分子硫酸エステルを合成してアフイニテイクロマト
グラフイ用ゲルを調製する試みがされている。そのよう
な物質として、例えば、セルロース硫酸、デキ又トラン
硫酸、フンドロイチンボリ硫酸などがあり、これらはヘ
パリンと同様に血液凝固阻止作用、脂血清澄作用などを
有しまた塩基性有機物と結合して複合体を形成する性質
を示す。これら高分子硫酸エステル類はへパリ・ ンの
有する主要な性質をすべて具備しているのでそれらを総
称して「ヘパリフイド」と呼んでいる。
1935 Jorpes et al.
Since it was revealed that the anticoagulation effect of heparin is based on the presence of sulfate groups in the molecule, attempts have been made to synthesize polymeric sulfate esters to replace heparin and prepare gels for Affinity chromatography. ing. Examples of such substances include cellulose sulfate, dekimatatrans sulfate, fundroitin boris sulfate, etc. Similar to heparin, these substances have anticoagulant effects, lipid serum clarifying effects, etc., and also bind to basic organic substances. shows the property of forming a complex. These polymeric sulfate esters have all the major properties of heparin, so they are collectively called ``heparifides.''

このヘパリノイドをCNBr等でクロマトグラフィ用ゲ
ルに結合させてアフイニテイクロマトグラフイ用ゲルを
調製し、これを用いて凝固因子などを精製する方法が報
告されている(1例えば、米国特許第4,139.28
7号、特開昭5’2−114018号)。
A method has been reported in which this heparinoid is bound to a chromatography gel using CNBr or the like to prepare an affinity chromatography gel, and this is used to purify coagulation factors, etc. (1 For example, U.S. Pat. No. 4,139 .28
No. 7, Japanese Unexamined Patent Publication No. 5'2-114018).

しかしなが呟このような方法でも、ヘパリフイド自体が
高価であり、しかもヘバリノイドをゲル担体に結合させ
る方法が煩雑で、かつその結合が比較的弱く、しばしば
結合されたヘパリノイドが脱離するという難点がある。
However, even with this method, the heparinoid itself is expensive, and the method of binding the heparinoid to the gel carrier is complicated, and the binding is relatively weak, so the bound heparinoid often detaches. be.

2皿り1伯 本発明者らは、アフイニテイクロマトグラフイ用として
すぐれた特性を有する改良されたゲルを見出すべく種々
研究を重ねた結果、非架橋セルロースの固体粒状粒子を
その固体粒状状態を保持しなから硫酸エステル化したの
ちアルカリで中和して得られるゲルがヘパリン様の親和
性を有しアフイニテイクロマトグラフイ用ゲルとしてき
わめてすぐれた特性を示すことを知り、本発明を完成す
るに至った。すなわち、本発明は群特異性を有し、各種
蛋白質、ウィルスなどの精製に有用な新規なアフィニテ
ィクロマトグラフィ用ゲルおよびその製造法を提供する
ものである。
As a result of various studies to find an improved gel with excellent properties for use in affinity chromatography, the inventors of the present invention have developed solid granular particles of non-crosslinked cellulose in a solid granular state. The present invention was completed based on the knowledge that the gel obtained by sulfuric acid esterification without retention and neutralization with alkali has heparin-like affinity and exhibits extremely excellent properties as a gel for Affinity chromatography. reached. That is, the present invention provides a novel gel for affinity chromatography that has group specificity and is useful for purifying various proteins, viruses, etc., and a method for producing the gel.

発明の構成および効果 本発明の7フイニテイクロマトグラフイ用ゲルは、非架
橋セルロースを硫酸エステル化して得られるものであっ
て、好ましくは結晶セルロースあるいは結晶領域および
非結晶領域からなるセルロースを硫酸エステル化したも
のである。この場合、得られたセルロース硫酸エステル
は原料の形状を保持し、水性溶媒に不溶性であり、物理
的安定性にすぐれ、クロマトグラフィ用ゲルとして好適
である。これらの原料セルロース類はすでに市販されて
おり、例えばセルロファインGC−15、同GH−25
、同GO−100、同GC−200(チッソ社製)、ア
ビセル(旭化成工業社製)などがある。
Structure and Effects of the Invention The gel for 7 Finitei chromatography of the present invention is obtained by sulfuric acid esterification of non-crosslinked cellulose, preferably crystalline cellulose or cellulose consisting of a crystalline region and an amorphous region, which is obtained by sulfuric acid esterification of crystalline cellulose or cellulose consisting of a crystalline region and an amorphous region. It has become. In this case, the cellulose sulfate ester obtained retains the shape of the raw material, is insoluble in aqueous solvents, has excellent physical stability, and is suitable as a gel for chromatography. These raw material celluloses are already commercially available, such as Cellulofine GC-15 and Cellulofine GH-25.
, GO-100, GC-200 (manufactured by Chisso Corporation), and Avicel (manufactured by Asahi Kasei Industries, Ltd.).

本発明の7フイニテイクロマトグラフイ用ゲルを製造す
るには、硫酸エステル化剤をアミンまたはアミドに溶解
し、これに非架橋セルロースの粒状物を反応させ、つい
でアルカリで中和することにより行なわれる。
In order to produce the gel for 7 Finitei chromatography of the present invention, a sulfuric acid esterifying agent is dissolved in an amine or an amide, and non-crosslinked cellulose particles are reacted with this, followed by neutralization with an alkali. It will be done.

硫酸エステル化剤としては無水硫酸またはクロルスルホ
ン酸が好ましいが、その他、硫酸、濃硫酸、発煙硫酸、
ピロ硫酸、スルファミン酸などら用いられる。しかし、
条件によっては、セルロースの加水分解を進行させるt
こめ、少なくとも原料セルロースの粒状状態を保持する
限度内で硫酸エステル化を行なう必要がある。そのため
、硫酸エステル化剤は過剰に加えず、通常原料セルロー
ス100部(重量部、以下固し)に対して1〜150部
程度で用い、反応温度は一10〜ioo’c程度で、反
応時間は30分〜6時間程度とする。
As the sulfuric acid esterifying agent, sulfuric anhydride or chlorosulfonic acid is preferable, but sulfuric acid, concentrated sulfuric acid, fuming sulfuric acid,
Pyrosulfuric acid, sulfamic acid, etc. are used. but,
Depending on the conditions, cellulose hydrolysis may proceed.
Therefore, it is necessary to carry out the sulfuric acid esterification within a limit that at least maintains the granular state of the raw material cellulose. Therefore, the sulfuric acid esterification agent is not added in excess, but is usually used in an amount of about 1 to 150 parts per 100 parts (by weight, hereinafter referred to as solid) of raw material cellulose. The duration is approximately 30 minutes to 6 hours.

溶媒として用いるアミンまたはアミドとしてはピリジン
、トリエチルアミン、ジメチルホルムアミドなどが挙げ
られる。これに添加反応させる原料セルロースはカラム
クロマトグラフィ用として市販の粒径的15〜150μ
Inの粒状物を含水率1%程度まで乾燥して用いる。
Examples of the amine or amide used as a solvent include pyridine, triethylamine, and dimethylformamide. The raw material cellulose to be reacted with this is a commercially available cellulose for column chromatography with a particle size of 15 to 150μ.
In granules are dried to a moisture content of about 1% before use.

アルカリによる中和は、水酸化ナトリウム、水酸化カリ
ウム、水酸化マグネシウムなどの適当な濃度の水溶液ま
たはメタノール性水溶液を用いて行なわれる。この中和
反応は通常発熱を伴なうため、氷水やドライアイスエタ
ノール冷媒などで充分に冷却し、反応温度を50°C以
上に上昇させないように留意する。
Neutralization with an alkali is carried out using an aqueous solution or a methanolic aqueous solution of sodium hydroxide, potassium hydroxide, magnesium hydroxide, etc. at an appropriate concentration. Since this neutralization reaction is usually accompanied by heat generation, it is sufficiently cooled with ice water or dry ice ethanol refrigerant, and care is taken not to raise the reaction temperature above 50°C.

本発明によるセルロースの硫酸エステル化は、例えば下
記式 で示されるようにセロビオース基の6位の水酸基が最も
反応性が高いため、この水酸基が硫酸化されるものと考
えられる。しかし、実際に硫酸化される割合は外わめて
僅かで、後記実施例における元素分析値からも明らかな
ようにSまたはNaとして理論量の約1%程度が硫酸化
される。したがって、本発明のセルロース硫酸エステル
は、セルロースモノ硫酸エステル(それは水溶性)とな
っているのではなく、セルロースの非結晶領域部分のみ
が、しかもその大部分はきわめて表面の薄い層のみが、
モノエステル化されたものと考えられ、このような硫酸
エステル化さ1れた非結晶領域セルロースと結晶領域セ
ルロースとの分子間相互作用により水不溶性を保つもの
と思われる。なお、蛋白質などとの親和性に関与するの
は粒状セルロースのきわめて薄い表面層のみで充分であ
る。
In the sulfuric acid esterification of cellulose according to the present invention, for example, as shown in the following formula, the hydroxyl group at the 6-position of the cellobiose group has the highest reactivity, so it is thought that this hydroxyl group is sulfated. However, the actual proportion of sulfation is extremely small, and as is clear from the elemental analysis values in Examples described later, about 1% of the theoretical amount of S or Na is sulfated. Therefore, the cellulose sulfate ester of the present invention is not a cellulose monosulfate ester (which is water-soluble), but only the non-crystalline region of cellulose, most of which is an extremely thin layer on the surface.
It is thought that it has been monoesterified, and it is thought that it maintains its water insolubility due to the intermolecular interaction between the sulfuric acid esterified non-crystalline cellulose and the crystalline cellulose. Note that only the extremely thin surface layer of the granular cellulose is sufficient to be involved in the affinity with proteins and the like.

上記の方法で、得られる本発明の7フイニテイクロマト
グラフイ用ゲルは、粒径的15〜150μIIIの非架
橋セルロース硫酸エステルの水不溶性固体粒状粒子から
なる。
The gel for 7 Finitei chromatography of the present invention obtained by the above method consists of water-insoluble solid particulate particles of non-crosslinked cellulose sulfate ester having a particle size of 15 to 150 μIII.

本発明の群特異性アフイニテイクロマトグラフイ用ゲル
は、各種蛋白質、ウィルス類の精製にきわめて有用であ
る。効果的に適用される蛋白質、ウィルス類としては、
例えば、下記のような特異性をする群がある。
The group-specific affinity chromatography gel of the present invention is extremely useful for purifying various proteins and viruses. Proteins and viruses that can be effectively applied include:
For example, there are groups that have the following specificities.

百日せき菌などの産生する蛋白質F−HA(F ila
mentous He+naHglutinin)およ
び/またはLPF    HA(Leucocytos
ispro+noLingfacLor1+e+oag
glutinin) B型肝炎ウィルス(HBV)およびその抗原 (HBc
AFl、HBsAg)、またはこれらの形質転換動物細
胞由来または形質転換微生物由来の発現抗原または蛋白
質 単純ヘルペスウィルス蛋白質(H8VgB)、 よたけ
その形質転換動物細胞由来または形質転換微生物由来の
発現抗原または蛋白質 インフルエンザウィルス(ヒト、ウマ、ブタ、トリ)、
 日本脳炎ウィルス、狂犬病ウィルス、イバラキウイル
ス、ウシ流行熱ウィルス、ブタパルボウイルス、イヌバ
ルボウイルス、オーエスキーウィルス、ニューカッスル
ウィルス、ガンポロ病つィルスなど、および/またはこ
れらの形質転換動物細胞または形質転換微生物に由来す
る産生物質 アンチトロンビンIII、血液凝固因子、血小板第4因
子、リボ蛋白リパーゼ、または補体成分などの生理活性
を有する蛋白質 ウロキナーゼ、インベルターゼなどの動物、植物、微生
物などの生物体由来の酵素 本発明の7フイニテイクロマトグラフイ用ケ゛ルを用い
て上記各種蛋白質、ウィルスなとの吸着、;5出を行な
うには通常のカラムクロマトグラフィで採用される操作
か適用されるが、その条件は吸着または溶出すべき蛋白
質またはウィルスの種類によって異なる。しかし、一般
的な繰作条件としては、該ゲルをカラムに充填し、p)
(s、o〜9゜0、比電導度0,5〜25 、0 +n
s/ c+++の緩衝液であらかじめ平衡化し、これに
pH5,0〜980、温度O〜60°C1比電導度0.
5〜25.0+晶Is/ C111の条件下で処理すべ
き蛋白質またはウィルスを吸着せしめ、ついで前記平衡
化に用いたものと同じ緩衝液またはそれより比電導度の
大きい緩衝液で洗浄し、最後に、イオン強度が上記平衡
化および洗浄に用いた緩衝液よりも大きい、pH5,0
〜10゜0、比電導度5.0〜130+ns/cmの緩
衝液を用いて溶出することにより、高度に精製された蛋
白質またはウィルスを得ることができる。なお、該精製
操作はバッチ法、カラム法のいずれでも行なうことかで
きる。
Protein F-HA (Fila) produced by Bordetella pertussis etc.
mentous He+naHglutinin) and/or LPF HA (Leucocytos
ispro+noLingfacLor1+e+oag
glutinin) hepatitis B virus (HBV) and its antigen (HBc
AFl, HBsAg), or expressed antigens or proteins derived from these transformed animal cells or transformed microorganisms. Herpes simplex virus protein (H8VgB), expressed antigens or proteins derived from transformed animal cells or transformed microorganisms. Viruses (human, horse, pig, bird),
Japanese encephalitis virus, rabies virus, Ibaraki virus, bovine epidemic virus, porcine parvovirus, canine balbovirus, Aujesky virus, Newcastle virus, Gampolo virus, etc., and/or transformed animal cells or microorganisms thereof. Antithrombin III, blood coagulation factors, platelet factor 4, riboprotein lipase, or proteins with physiological activities such as complement components Enzymes derived from living organisms such as animals, plants, and microorganisms, such as urokinase and invertase In order to adsorb and extract the various proteins, viruses, etc. described above using the 7F chromatography column of the invention, operations employed in ordinary column chromatography are applied, and the conditions for the adsorption or Depends on the type of protein or virus to be eluted. However, as a general operation condition, the gel is packed into a column, p)
(s, o~9゜0, specific conductivity 0.5~25, 0+n
Equilibrate in advance with a buffer solution of s/c+++, and add to this a pH of 5.0 to 980, a temperature of O to 60°C, a specific conductivity of 0.
The protein or virus to be treated is adsorbed under conditions of 5 to 25.0 + Crystal Is/C111, then washed with the same buffer used for the equilibration or a buffer with a higher specific conductivity, and finally at pH 5.0, the ionic strength of which is greater than that of the buffer used for the equilibration and washing.
A highly purified protein or virus can be obtained by elution using a buffer solution having a temperature of ~10°0 and a specific conductivity of 5.0 to 130+ns/cm. Incidentally, the purification operation can be carried out by either a batch method or a column method.

上記精製操作について、百日せき菌の産生する蛋白質で
あるF−HAおよびLPF−HAの単離精製の場合を例
にとってさらに具体的に説明すれば下記のとおりである
The above purification operation will be described in more detail below, taking as an example the isolation and purification of F-HA and LPF-HA, which are proteins produced by Bordetella pertussis.

(1)  F−HAの単離精製 後記実施例1で得られるセルロース硫酸エステルゲルは
、あらカルめ例えば0.2M塩化ナトリウム添加0.0
1M’Jン酸緩衝液等の、中性側近のpH値(p’86
〜9)であり、比電導度5〜25m5 / c m程度
の適当な緩衝液を用いて平衡化を行なった後に、F−H
Aの吸着操作に供する。
(1) Isolation and purification of F-HA The cellulose sulfate ester gel obtained in Example 1 described below is prepared by adding 0.2 M sodium chloride to the gel.
The pH value of a neutral buffer such as 1M'J acid buffer (p'86
~9), and after equilibration using an appropriate buffer solution with a specific conductivity of about 5 to 25 m5/cm, F-H
Used for adsorption operation of A.

セルロース硫酸エステルゲルへのF−HAの吸着、ゲル
の洗浄、F−HAの溶出等一連の精製操作は、バッチ法
お上びカラム法等の工業的に通常よく用いられる操作方
法で行なう。バッチ法で行なう場合は、百日せき菌培養
物中にセルロース硫酸エステルゲルを投入し、pH6,
0〜9.0程度の範囲において0〜30 ’C程度の温
度にて10〜60分程度緩く撹拌してF−HAを吸着さ
せる。
A series of purification operations such as adsorption of F-HA onto the cellulose sulfate ester gel, washing of the gel, and elution of F-HA are carried out by commonly used industrial methods such as a batch method and a column method. When performing the batch method, add the cellulose sulfate gel to the Bordetella pertussis culture and adjust the pH to 6.
F-HA is adsorbed by stirring gently for about 10 to 60 minutes at a temperature of about 0 to 30'C in a range of about 0 to 9.0°C.

この際、百日せき菌培養物の比電導度が5.0〜25 
、0 ms/c+o程度となるように、適宜濃縮または
希釈して吸着繰作に付す。
At this time, the specific conductivity of the B. pertussis culture is 5.0 to 25.
, 0 ms/c+o, as appropriate, and subjected to adsorption cycles.

吸着終了後、培養物−ゲル混合欣を濾過器上に充」眞し
、吸引シ濾過してゲルとろ液を分離する。分離したゲル
を、比電導度5〜25+ns/eta程度で、pHが5
.0〜10.0程度である適当な緩衝液例えば、0.2
M塩化ナトリウム添加0.02Mマツキルベン(Me 
I 1vaine’s)緩衝液、0.3M塩化ナトリウ
ム添加0.01Mリン酸緩衝液あるいは0.3M塩化ナ
トリウム添加0.OIM)リス塩酸緩衝液等を注ぎ吸引
して洗浄する。
After the adsorption is completed, the culture-gel mixture is filled onto a filter and filtered with suction to separate the gel and the filtrate. The separated gel has a specific conductivity of about 5 to 25+ns/eta and a pH of 5.
.. A suitable buffer solution having a concentration of about 0 to 10.0, for example, 0.2
M Sodium Chloride Added 0.02M Pine Kirbene (Me
I 1vaine's) buffer, 0.01M phosphate buffer with 0.3M sodium chloride, or 0.01M phosphate buffer with 0.3M sodium chloride. OIM) Pour lithium-hydrochloric acid buffer, etc. and aspirate to wash.

この後、l)Hが5.0〜10.0程度で、比電導度か
25〜130ms/c+n程度である(上記洗浄用緩衝
液の比電導度より大)適当な緩衝液、例えば1.5M塩
化ナトリウム添加マツキルベン緩衝液、1.5M塩化す
) IJウム添加リン酸緩衝液等を注ぎ、吸着している
F−HAを溶出する。
After this, l) an appropriate buffer solution having a H of about 5.0 to 10.0 and a specific conductivity of about 25 to 130 ms/c+n (greater than the specific conductivity of the above-mentioned washing buffer), for example 1. Pour 5M sodium chloride-added pine kilbene buffer, 1.5M sodium chloride-added phosphate buffer, etc. to elute the adsorbed F-HA.

カラム法にて実施する場合は、原材料液、洗浄用緩衝液
、溶出用緩衝液の条件はバッチ法の場合と同様でよく、
これらの通液速度は10+IIl/era2/ Hr−
500+ol/cm2/ Hr程度に調整して行なうと
よい。
When using the column method, the conditions for the raw material solution, washing buffer, and elution buffer may be the same as for the batch method.
These liquid passing rates are 10+IIl/era2/Hr-
It is advisable to adjust the pressure to about 500+ol/cm2/Hr.

上記方法によれば、セルロース硫酸エステルゲルの百日
せき菌培養物中のF −HAの特異的吸着能にすぐれ、
F−HAの精製度は従来法に比し数十倍に達し、しかも
F−HAの回収率は90%以上100%近くに達する。
According to the above method, the cellulose sulfate ester gel has excellent specific adsorption ability for F-HA in B. pertussis culture,
The degree of purification of F-HA is several tens of times higher than that of conventional methods, and the recovery rate of F-HA is 90% or more and nearly 100%.

得られる精製F−HAの比活性は4〜8X10’HAユ
ニツ)/B蛋白質ときわめて高く、ポリアクリルアミド
ディスク電気泳動(pH4,5)分析において単一のバ
ンドを形成し、百日せ5菌内毒素がほぼ完全に除去され
る。
The specific activity of the purified F-HA obtained was extremely high, 4 to 8 x 10'HA units)/B protein, and it formed a single band in polyacrylamide disk electrophoresis (pH 4, 5) analysis, indicating that Toxins are almost completely removed.

(2)LPF−)(Aの単離精製 原材料液であるLPF−HA含有液は、百日せき菌培養
物の遠心上清を、蒸留水または緩iΦj液で比電導度が
0.5〜5.Oms/c+oとなるように希釈した後、
吸着操作に付すこともできるが、この上清中にはセルロ
ース硫酸エステルゲルに対して同じく親和性を有するF
−HAが含まれているため、あらかじめ、L P F 
−HAは吸着せずF−HAを吸着する条件にて、セルロ
ース硫酸エステルゲルによるクロマトグラフィを行ない
、その素通り画分であるところのF−HAを含まずLP
F−HAを大量に含んだ両分を吸着操作に付す。
(2) LPF-) (LPF-HA-containing solution, which is the isolated and purified raw material solution of A, is obtained by mixing the centrifuged supernatant of a B. pertussis culture with distilled water or a slow iΦj solution with a specific conductivity of 0.5 to 5. After diluting to Oms/c+o,
It can also be subjected to an adsorption operation, but this supernatant contains F, which also has an affinity for cellulose sulfate gel.
-Since HA is included, L P F
- Perform chromatography using cellulose sulfate ester gel under conditions that adsorb F-HA without adsorbing HA, and use the LP that does not contain F-HA, which is the pass-through fraction.
Both portions containing a large amount of F-HA are subjected to an adsorption operation.

セルロース硫酸エステルゲルへのLPF−HAの吸着、
ゲルの洗浄、LPF−HAの溶出部一連の精製繰作は、
バッチ法およびカラム法等の工業的に通常よく用いられ
る操作方法で行なうことができるが、カラム法の方が操
作が簡単であり好都合である。カラム法の場合、セルロ
ース硫酸エステルゲルをカラムに充填し、あらかじめ例
えば0゜02Mマツキルベン緩衝液(pH5,2)等の
比電導度0,5−5.0ms/cmでpHが5.0−9
.0程度である適当な緩衝液を通液して平衡化を行った
後に、LPF−HAの吸着操作に移る。
Adsorption of LPF-HA onto cellulose sulfate gel,
A series of purification steps including washing the gel and elution part of LPF-HA are as follows:
This can be carried out using commonly used industrial methods such as a batch method and a column method, but the column method is easier and more convenient. In the case of the column method, a cellulose sulfate ester gel is packed in a column, and the pH is adjusted to 5.0-9 with a specific conductivity of 0.5-5.0 ms/cm, such as 0.02 M pine kilbene buffer (pH 5.2).
.. After equilibration is carried out by passing a suitable buffer solution having a concentration of approximately 0.0, the LPF-HA adsorption operation is started.

吸着に際しては、LPF−HAの含有液をl)Hが5.
0〜9.0、比電導度が0.5〜5.0になるように適
宜調整して、セルロース硫酸エステルゲル充填カラムに
通渡し、LPF−HAを吸着させる。この後、前述の平
衡化に用いたのと同様の緩衝液を通液し、ゲルを洗浄し
、夾雑物質を洗い出す。
During adsorption, the solution containing LPF-HA was prepared with l) H of 5.
0 to 9.0 and the specific conductivity to 0.5 to 5.0, and passed through a column packed with cellulose sulfate gel to adsorb LPF-HA. Thereafter, a buffer similar to that used for the above-mentioned equilibration is passed through to wash the gel and wash out contaminants.

LPF−14Aの溶出に際しては、l)Hか5.()〜
9.0、比電導度か5 、0 +ns/can以上であ
る適当な緩衝液を通渡し溶出を行なうが、好ましくは段
階溶出または塩濃度勾配溶出を行なう。すなわち、原材
料液として百日せき菌培養液の遠心上清の希釈したもの
をそのまま用いる場合は、前述の吸着条件下において、
LPF−HAと同時にF−)(Aも吸着されてくるので
、L P F −HAが溶出さJt、かつF−HAが溶
出されない条件下で溶出する必要がある。この条件とし
ては1)H5〜9において比電導度5〜100 ms/
 am、’好ましくは50〜60 ms/canである
適当な緩衝液(例えばl)、7M塩化ナトリウム添加0
.02Mマツキルベン緩衝液)を最初に通液し、LPF
−HAを含む両分を回収する。この後に上述の溶出用緩
衝液より比電導度の大なる( 100−300+++s
/cm)緩衝液を通液し、F−HAその地の不純成分を
溶出させ、セルロース硫酸エステルゲルを平衡化再使用
に供する。
For elution of LPF-14A, either 1) H or 5. ()~
Elution is carried out by passing through an appropriate buffer solution having a specific conductivity of 9.0 and a specific conductivity of 5.0 + ns/can or more, preferably stepwise elution or salt concentration gradient elution. That is, when using the diluted centrifuged supernatant of B. pertussis culture as the raw material solution, under the above-mentioned adsorption conditions,
Since F-) (A is also adsorbed at the same time as LPF-HA, it is necessary to elute under conditions where LPF-HA elutes Jt and F-HA does not elute. These conditions include 1) H5 -9 specific conductivity 5-100 ms/
am, 'preferably 50-60 ms/can in a suitable buffer (e.g. l), 7M sodium chloride added 0
.. 02M pine kilbene buffer) was first passed through the LPF.
- Collect both parts containing HA. After this, the elution buffer with a higher specific conductivity than the above elution buffer (100-300+++s
/cm) buffer solution is passed through to elute impurity components present in the F-HA, and the cellulose sulfate ester gel is equilibrated and reused.

最も好ましくは、塩濃度勾配溶出を実施する。Most preferably, a salt gradient elution is performed.

原材料液として、あらかじめF7HAを分離したLPF
−HA含有液を用いる場合においても、比電導度が0.
5→300m5/cmとなるような塩濃度勾配緩衝液(
例えば塩化ナトリウムO→4.OM塩濃度勾配・0.0
2Mマツキルベン緩衝液(pH5,2)を用いて溶出を
行ない、LPF−HA含有画分を分取すれば、きわめて
高純度のLPF−HAを得ることができる。
LPF from which F7HA has been separated in advance as a raw material liquid
- Even when using an HA-containing liquid, the specific conductivity is 0.
Salt concentration gradient buffer (5 → 300 m5/cm)
For example, sodium chloride O→4. OM salt concentration gradient 0.0
If elution is performed using 2M pine kilbene buffer (pH 5.2) and a fraction containing LPF-HA is collected, LPF-HA of extremely high purity can be obtained.

上記の精製法によれば、L P F −HAの精製度は
従来法に比し数十倍に達し、しかもLPF−HAの回収
率は90%以上100%近くに達する。
According to the above purification method, the degree of purification of LPF-HA reaches several tens of times compared to the conventional method, and the recovery rate of LPF-HA reaches 90% or more and nearly 100%.

得られる精製LPF−HAの比活性は9X10’LPE
U/ll1g蛋白質ときわめて高く、ポリアクリルアミ
ドディスク電気泳動(pH4,5)分析において単一の
バンドを形成し、百日せき菌内毒素がほぼ完全に除去さ
れる。
The specific activity of the purified LPF-HA obtained is 9X10'LPE.
It has an extremely high protein content of U/11g protein, forms a single band in polyacrylamide disc electrophoresis (pH 4, 5) analysis, and Bordetella pertussis endotoxin is almost completely removed.

つぎに、本発明の7フイニテイクロマトグラフイ用ゲル
の製造に関する実施例およびそのゲルを用いた各種蛋白
質またはウィルスの精製に関する実験例を挙げて本発明
をさらに具体的に説明するが、本発明はこれらに限定さ
れない。
Next, the present invention will be explained in more detail by giving examples related to the production of a gel for 7 Finitei chromatography of the present invention and experimental examples related to the purification of various proteins or viruses using the gel. is not limited to these.

実施例1 0℃以下の温度にてピリジン600−に無水硫酸20g
を滴下し、混合する。滴下終了後、混液を30℃に保つ
。この中に含水率1%以下に乾燥したセルロファインG
C−15(チッソ社製)80gを加え、撹拌下30℃に
て3時間反応させる。
Example 1 20g of sulfuric anhydride in pyridine 600- at a temperature below 0°C
Add and mix. After the addition is complete, keep the mixture at 30°C. In this, Cellulofine G dried to a moisture content of 1% or less
80 g of C-15 (manufactured by Chisso Corporation) is added, and the mixture is reacted at 30° C. for 3 hours with stirring.

反応終了後、冷却し、5%水酸化ナトリウム水溶液を加
えて中和する。ゲルをシ濾過分離し、0.01Mリン酸
緩衝食塩液で充分に洗浄してセルロース硫酸エステルゲ
ルを得る。
After the reaction is completed, the mixture is cooled and neutralized by adding a 5% aqueous sodium hydroxide solution. The gel is separated by filtration and thoroughly washed with 0.01M phosphate buffered saline to obtain a cellulose sulfate gel.

元素分析値(測定値):C,40,4%、0,45゜8
%、H,6,3%、S、0.15% またナトリウム含量は1 + 400 mg/kgであ
る。
Elemental analysis value (measured value): C, 40.4%, 0.45°8
%, H, 6.3%, S, 0.15% and the sodium content is 1 + 400 mg/kg.

実施例2 0℃以下の温度にてピリ°ジン60(h、Q にクロル
スルホン酸117gを滴下し、混合する。滴下終了後、
混液を加熱し、65〜70°Cに昇温する。
Example 2 117 g of chlorosulfonic acid is added dropwise to pyridine 60 (h, Q) at a temperature below 0°C and mixed. After the addition is complete,
Heat the mixture to 65-70°C.

この中に結晶セルロースであるクロマトグラフィ用アビ
セル(旭化成工業社製)80gを加え、撹拌下65〜7
0 ’Cにて4時間保持する。反応終了後、冷却し 1
0%水酸化す) +7ウム水溶液を加えて中和する。ゲ
ルを濾過分離し、0.OIMリン酸緩衝食塩液で充分に
洗浄してセルロース硫酸エステルゲルを得る。
Add 80 g of crystalline cellulose, Avicel for chromatography (manufactured by Asahi Kasei Industries, Ltd.), and add 65 to 70 g of crystalline cellulose while stirring.
Hold at 0'C for 4 hours. After the reaction is completed, cool 1
Neutralize by adding +7um aqueous solution (0% hydroxide). The gel was separated by filtration and 0. Wash thoroughly with OIM phosphate buffered saline solution to obtain cellulose sulfate ester gel.

実験例1 (HBs抗原の精製) 前記実施例1で得られたセルロース硫酸エステルゲルを
充填したカラム(26,4+面φX 1 (’) 5 
m+Jに、0.05M塩化ナトリウムを含む0.027
Mマノキルベン緩衝液(p)(7,20)を通し平衡化
する。このカラムにHBs抗原陽性人血清20mlを上
記緩衝液で3倍量に希釈したものを通液する。
Experimental Example 1 (Purification of HBs antigen) A column packed with the cellulose sulfate gel obtained in Example 1 (26,4+face φX 1 (') 5
0.027 containing 0.05M sodium chloride in m+J
Equilibrate through M manokilbene buffer (p) (7,20). 20 ml of HBs antigen positive human serum diluted 3 times with the above buffer solution is passed through this column.

その後、上記緩衝液で充分に洗浄する。ついで、0.6
M塩化ナトリウムを含む0.027Mマツキルベン緩衝
液(pH7,20)で溶出する。この結果を第1表に示
す。第1表に示すように、)(Bs抗原は溶出画分にほ
ぼ回収され、精製度は約16倍に達した。
Then, wash thoroughly with the above buffer solution. Then, 0.6
Elute with 0.027M pine kilbene buffer (pH 7.20) containing M sodium chloride. The results are shown in Table 1. As shown in Table 1, ) (Bs antigen was almost completely recovered in the elution fraction, and the degree of purification reached approximately 16 times.

第  1  表 *1)  ラノオイム/アッセイ(グイナボット社製、
オーセリアll−125)で測定。
Table 1 *1) Lanoium/assay (manufactured by Guinabot,
Measured with Auxeria ll-125).

(黒用正身、斉藤晴−: Japan−J、Med。(Kuroyo Seishin, Saito Haru: Japan-J, Med.

Sci、Biol、、32・47−52(1979)を
参照) 木2)流出液と洗浄液を含む。
Sci, Biol, 32:47-52 (1979)) Wood 2) Contains effluent and wash liquor.

実験例2 (F −HAの精製) 前記実施例1と同様にして調製したセルロース硫酸エス
テルゲルをカラム(16+n+oφX100m+Il)
に充填し、これに0.2 M塩化ナトリウム添加0.0
1Mリン酸緩衝液(pH8,0、比電導度的17 、5
 ms/cm)を通液して平衡化する。このカラムに百
日ぜきI相菌東浜株ファーメンタ−培養上清800Jを
希釈して、比電導度的17.5Qlξ/am 、  l
)88 、0に合わせた液を通液する。通液後、上記緩
衝液にて洗浄し、夾雑物質を洗い出す。
Experimental Example 2 (Purification of F-HA) Cellulose sulfate gel prepared in the same manner as in Example 1 was applied to a column (16+n+oφX100m+Il).
to which 0.2 M sodium chloride was added 0.0
1M phosphate buffer (pH 8.0, specific conductivity 17.5
ms/cm) to equilibrate. 800 J of pertussis I phase fungus Higashihama strain fermentor culture supernatant was diluted into this column, and the specific conductivity was 17.5 Qlξ/am, l.
)88, Pour the solution adjusted to 0. After passing through the solution, it is washed with the above buffer solution to wash out contaminants.

ついで、1.5M塩化ナトリウム添加リン酸緩衝液(p
H7,6)で溶出し、F−HAを含む両分30mj2を
得る。
Then, 1.5M sodium chloride-added phosphate buffer (p
Elute with H7,6) to obtain 30 mj2 of both fractions containing F-HA.

培養上清液および、素通り画分、精製F−)(A画分の
分析結果を第2表に記す。
The analysis results of the culture supernatant, flow-through fraction, purified F-) (A fraction) are shown in Table 2.

F−HAの回収率は93.8%で、精製度(精製F−H
A画分の比活性/培養上清の比活性)は34倍に達した
。精製F−HA画分のLPF−HA活性は、ハブ)EL
ISA法[佐藤呟第28回毒素シンポジウム予稿集14
1(1981)]による分析でl0ELISAユニツ)
/mj2以下であった。
The recovery rate of F-HA was 93.8%, and the purity (purified F-H
The specific activity of fraction A/specific activity of culture supernatant) reached 34 times. LPF-HA activity of purified F-HA fraction was determined by HUB)EL
ISA method [Tsumi Sato Proceedings of the 28th Toxin Symposium 14
1 (1981)], 10ELISA Units)
/mj2 or less.

第2表 J)F−HA血球凝集試験[5ato、 Y、eL a
l+  I訂ecL。
Table 2 J) F-HA hemagglutination test [5ato, Y, eLa
l+ I revised ecL.

Immun、、 7,929−999(1973)]2
)キルブール法蛋白窒素測定値X6,25により蛋白質
含量として表示 3)HA価/蛋白質含量 4)5)6.25μg蛋白質/m lの含量に希釈後、
生物学的製剤基準(薬発287号、1981)に循ヒて
実施した。
Immun, 7, 929-999 (1973)]2
) Displayed as protein content using Kirbourg method protein nitrogen measurement value
The test was carried out in accordance with the Biological Products Standards (Yakuhatsu No. 287, 1981).

実験例3(LPF−HAの精製) 前記実施例1と同様にして調製したセルロース硫酸エス
テルゲル に充填し、これに蒸留水1.Ol を通液する。このカ
ラムに百日せき■相菌束浜株静置培養液の遠心上清50
0Jを蒸留水で10倍希釈しだ液(比電導度的1 、 
5 ms/cm)を通液する。約5 0 0Jの0、0
2Mマツキルベン緩衝液(pH5.2)をカラムに通液
し、ゲルを洗浄した後、0.02M塩化ナトリウム添加
マツキルベン緩衝液(比電導度的2、0+ns/c++
+.pH5.2)2000−を用ν1、塩化ナトリウム
O→4.OMの塩濃度勾配にて溶出を行ない、約20m
lずつ分画して分取した後、LPF−HAを含有する両
分的130Jをプールする。
Experimental Example 3 (Purification of LPF-HA) A cellulose sulfate ester gel prepared in the same manner as in Example 1 was filled, and 1. Pass the Ol solution through. In this column, 50% of the centrifuged supernatant of a standing culture of Pertussis
0J diluted 10 times with distilled water (specific conductivity 1,
5 ms/cm). 0,0 of about 500J
After passing 2M pine kilbene buffer (pH 5.2) through the column and washing the gel, pine kirbene buffer containing 0.02 M sodium chloride (specific conductivity 2, 0+ns/c++
+. pH5.2) 2000- ν1, sodium chloride O→4. Elution was performed using a salt concentration gradient of OM, approximately 20 m
After fractionation and fractionation, 130 J of both fractions containing LPF-HA are pooled.

原材料液および精製LPF−HA画分の分析結果および
実験成績を第3表に示す。
Table 3 shows the analysis results and experimental results of the raw material solution and purified LPF-HA fraction.

第3表 1)LPF−HAのin viLroテスト:ハプト−
ELISA法[佐藤呟第28回毒素シンポジウム予稿集
141−144(1981)を参照]によるLPF−H
Aの単位 2)キルタール法蛋白窒素測定値X6.25により蛋白
質含量として表示 3)  6.25μg蛋白質/mlの含量に希釈後、生
物学的製剤基準(薬発287号、1981)に準じて不
活化して実施した。
Table 3 1) In viLro test of LPF-HA: Hapto-
LPF-H by ELISA method [see Tsutomu Sato 28th Toxin Symposium Proceedings 141-144 (1981)]
Unit of A2) Displayed as protein content based on the protein nitrogen measurement value X6.25 using the Kirtar method.3) After dilution to a content of 6.25 μg protein/ml, it was determined to be non-defective in accordance with the Biological Product Standards (Yakuhatsu No. 287, 1981). It was revitalized and implemented.

1例4(インフルエンザウィルスの精製)前記実施例1
で得られたセルロース硫酸エステルゲルをカラム(5c
mφX17c+n)に充填し、これにo.14M塩化ナ
トリウムを含む0.010Mリン酸緩衝液(pH7.4
)を通液し平衡化する。このカラムに11日令のふ化鶏
卵に接種培養(34℃、48時間ルだA/フィリピン(
83N2)タイプインフルエンザウィルス感染尿膜膣液
[ウィルス量77CCA、蛋白質窒素量377μg/m
ffi (o −ソー法)、比活性(OCA/TCA−
N)0.2014、200Inf!.を通液する。その
後に0.19M塩化ナトリウムを含む0,01Mリン酸
緩衝液2500+Jを通して洗浄する。ついで、1.4
9M塩化ナトリウムを含む0.0 10Mりン酸緩衝液
で溶出し、溶出画分17(h,9を得る。その後、4。
1 Example 4 (Purification of Influenza Virus) Above Example 1
The cellulose sulfate gel obtained in
mφX17c+n), and o. 0.010M phosphate buffer containing 14M sodium chloride (pH 7.4)
) to equilibrate. This column was inoculated and cultured with 11-day-old hatched chicken eggs (34℃, 48 hours) A/Philippines (
83N2) Type influenza virus infected allantoic vaginal fluid [viral amount 77CCA, protein nitrogen amount 377 μg/m
ffi (o-saw method), specific activity (OCA/TCA-
N) 0.2014, 200Inf! .. Pass the liquid through. This is followed by washing with 2500+J of 0.01M phosphate buffer containing 0.19M sodium chloride. Then, 1.4
Elute with 0.0-10M phosphate buffer containing 9M sodium chloride to obtain elution fraction 17 (h, 9. Then, 4.

99M塩化ナトリウムを含む0,OIMリン酸緩+11
j液でゲルを溶出洗浄する。
0, OIM phosphoric acid mild +11 containing 99M sodium chloride
Elute and wash the gel with J solution.

この結果を第4表に示す。The results are shown in Table 4.

第4表 *)    CCA(cl+ick  cell  a
gglutination)  =鶏赤血球凝集反応に
より測定したウィルス量の単位、比活性とは、トリクロ
ル酢酸を用いて沈殿させた蛋白質窒素量を比色定量し、
その値(TCA−N)とウィルス量(CCA)との比で
蛋白質窒素量当りのウィルス(抗原)量を示す。
Table 4*) CCA (cl+ick cell a
gglutination) = unit of virus amount measured by chicken hemagglutination reaction, specific activity is determined by colorimetrically quantifying the amount of protein nitrogen precipitated using trichloroacetic acid.
The ratio of the value (TCA-N) to the amount of virus (CCA) indicates the amount of virus (antigen) per amount of protein nitrogen.

第4表に示すように、インフルエンザ゛ウィルス。 は
溶出画分にはパ回収され、精製度は約20倍に達した。
As shown in Table 4, influenza virus. was recovered in the elution fraction, and the degree of purification reached approximately 20 times.

実験例5(日本脳炎ウィルスの精製) 前記実施例1と同様にして調製したセルロース硫酸エス
テルゲル37.5Jをカラム(25mmφX 400m
n+)に充填し、これに蒸留水375Jを通液する。次
に、0.14MNaC,(添加0.01Mリン酸緩衝液
375Jにてゲルを平衡化したのちこのカラムにプロタ
ミン−歳末処理して得られる不活化日本脳炎ウィルス浮
遊液50+Jを通液する。0.14M NaC1添加0
,01Mリン酸緩衝液にて、ゲルを十分洗浄した後、1
.5MNaC1添加100MIJン酸緩衝液(比電導度
的120m5/etQ、pH7,2)100Jを用いて
溶出を行ない、約5−ずつ分画して分取した後、日本脳
炎ウィルスを含有する両分的10J  をプールする。
Experimental Example 5 (Purification of Japanese Encephalitis Virus) 37.5J of cellulose sulfate gel prepared in the same manner as in Example 1 was placed in a column (25mmφX 400m
n+), and 375 J of distilled water was passed through it. Next, after equilibrating the gel with 375 J of 0.14 M NaC (additional 0.01 M phosphate buffer), 50+ J of an inactivated Japanese encephalitis virus suspension obtained by protamine-end treatment was passed through this column. 0.14M NaCl addition 0
After thoroughly washing the gel with 01M phosphate buffer,
.. Elution was performed using 100 J of 100 MIJ acid buffer (specific conductivity 120 m5/etQ, pH 7.2) supplemented with 5 M NaCl, and after fractionation into approximately 5-fold fractions, both fractions containing Japanese encephalitis virus were separated. Pool 10J.

原材料液および精製日本脳炎ウィルス画分の分析結果お
よび実験成績を第5表に示す。
Table 5 shows the analysis results and experimental results of the raw material liquid and purified Japanese encephalitis virus fraction.

第5表 実験例6(狂犬病ウィルスの精製) 前記実施例1と同様にして調製したセルロース硫酸エス
テルゲル0,141をカラム(2、5n++nφX 4
00 +nm)に充填し、これに蒸留水1400Jを通
液する。次に、0.14MNaCf添加0.OIMIJ
ン酸緩衝液1400+njgにてゲルを平衡化したのち
、このカラムにニワトリ胚初代培養細胞に接種増殖して
得られる不活性狂犬病ウィルス浮遊液2.9!を流速5
00m1/時間で通液する。
Table 5 Experimental Example 6 (Purification of Rabies Virus) Cellulose sulfate ester gel 0,141 prepared in the same manner as in Example 1 was applied to a column (2,5n++nφX 4
00 + nm), and 1400 J of distilled water was passed through it. Next, 0.14M NaCf was added. OIMIJ
After equilibrating the gel with 1,400+ njg of phosphate buffer, the inactive rabies virus suspension obtained by inoculating and proliferating primary cultured chicken embryo cells into this column was 2.9! The flow rate 5
The liquid is passed at a rate of 00ml/hour.

0.14M NaC1添加0.01Mリン酸緩衝液にて
、ゲルを十分洗浄した後、IMNaC,g添加0゜01
Mリン酸緩衝液(比電導度87 、6 ms/ can
、pH7,26)500mj2を用いて流速1 to 
l /分で溶出を行ない、約10Jづつ分画して分取し
た後、狂犬病ウィルスを含有する両分的30Jをプール
する。
After thoroughly washing the gel with 0.01M phosphate buffer containing 0.14M NaCl, add 0.01 g of IMNaC.
M phosphate buffer (specific conductivity 87, 6 ms/can
, pH 7,26) using 500 mj2 and a flow rate of 1 to
After elution is carried out at 1/min and fractionated into approximately 10 J fractions, 30 J of both fractions containing rabies virus are pooled.

原材料液および精製狂犬病ウィルス画分の分析結果およ
び実験成績を第6表に示す。
Table 6 shows the analysis results and experimental results of the raw material liquid and purified rabies virus fraction.

第6表 実験例7(アンチトロンビンIIIの精製)処理原料と
して新鮮凍結血漿を用い、これを解凍し、8000rp
mで30分間遠心分離し、その上清に分子14oooの
ポリエチレングリフール10%を加えて1時間撹拌し、
8000rpmで60分間遠心する。ついでこの上清を
、0.02Mリンera衝液(Na2HPO4・12H
20(0,2M、76%)とNaH2PO4・2H20
(0,2M、24%)の混合液)にて透析する。
Table 6 Experimental Example 7 (Purification of Antithrombin III) Fresh frozen plasma was used as a raw material for treatment, thawed and heated at 8000 rpm.
Centrifuged for 30 minutes at m, 10% polyethylene glyfur with 1400 molecules was added to the supernatant, and stirred for 1 hour.
Centrifuge at 8000 rpm for 60 minutes. Next, this supernatant was dissolved in 0.02M phosphorus era buffer (Na2HPO4.12H
20 (0.2M, 76%) and NaH2PO4・2H20
(0.2M, 24% mixed solution).

前記実施例1と同様にして調製したセルロース硫酸エス
テルゲル0.521を充填したカラム(1゜5canφ
X30cm)に、上記と同じ0 、02 Mリン酸緩衝
液を通してゲルを平衡化したのち、これに上記透析した
血漿上清20mff1(pH5,0)を通液する。つい
で、流出液の吸光度が充分に下るまで上記と同じ緩衝液
を流してカラムを洗浄したのち、溶出緩衝液(0,02
Mリン酸緩衝液+2 、 OM塩化ナトリウム)にて溶
出する。約10−づつ分画し、吸光度280nm(OD
2.。)での吸収ピークを示す2つの7ラクシヨンを得
る。この7ラクシヨンについて分析した結果を第7表に
示す。
A column packed with 0.521 cellulose sulfate gel prepared in the same manner as in Example 1 (1°5 canφ)
After equilibrating the gel by passing the same 0.02 M phosphate buffer as above into the gel, 20 mff1 of the dialyzed plasma supernatant (pH 5.0) was passed through the gel. Next, the column was washed with the same buffer as above until the absorbance of the effluent decreased sufficiently, and then the elution buffer (0.02
Elute with M phosphate buffer +2, OM sodium chloride). The absorbance was measured at 280 nm (OD
2. . ) are obtained, showing two 7-raction peaks at ). Table 7 shows the results of analysis of this 7-luxion.

第7表Table 7

Claims (4)

【特許請求の範囲】[Claims] (1)非架橋セルロースの固体粒状物を固体粒状状態を
保持しながら硫酸エステル化したのちアルカリで中和し
て得られる群特異性を有するアフィニティクロマトグラ
フィ用ゲル。
(1) A gel for affinity chromatography having group specificity obtained by converting solid particles of non-crosslinked cellulose into a sulfuric acid ester while maintaining its solid particle state and then neutralizing it with an alkali.
(2)該非架橋セルロースが結晶セルロースまたま結晶
領域および非結晶領域からなるセルロースである前記第
(1)項記載のゲル。
(2) The gel according to item (1) above, wherein the non-crosslinked cellulose is crystalline cellulose or cellulose consisting of a crystalline region and an amorphous region.
(3)硫酸エステル化剤をアミンまたはアミドに溶解さ
せ、これに非架橋セルロースの固体粒状物を反応させ、
ついでアルカリで中和することを特徴とする群特異性を
有するアフィニティクロマトグラフィ用ゲルの製造法。
(3) dissolving a sulfate esterification agent in an amine or amide and reacting it with solid particles of non-crosslinked cellulose;
A method for producing a gel for affinity chromatography having group specificity, which comprises then neutralizing with an alkali.
(4)硫酸エステル化剤が無水硫酸またはクロルスルホ
ン酸である前記第(3)項記載の方法。
(4) The method according to item (3) above, wherein the sulfuric acid esterifying agent is sulfuric anhydride or chlorosulfonic acid.
JP59177347A 1984-08-24 1984-08-24 Gel for affinity chromatography having group specificity and its production Granted JPS6154450A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59177347A JPS6154450A (en) 1984-08-24 1984-08-24 Gel for affinity chromatography having group specificity and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59177347A JPS6154450A (en) 1984-08-24 1984-08-24 Gel for affinity chromatography having group specificity and its production

Publications (2)

Publication Number Publication Date
JPS6154450A true JPS6154450A (en) 1986-03-18
JPH0423751B2 JPH0423751B2 (en) 1992-04-23

Family

ID=16029377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59177347A Granted JPS6154450A (en) 1984-08-24 1984-08-24 Gel for affinity chromatography having group specificity and its production

Country Status (1)

Country Link
JP (1) JPS6154450A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63209750A (en) * 1987-02-25 1988-08-31 Kanegafuchi Chem Ind Co Ltd Adsorbent for purifying viii th blood coagulation factor and process for purifying said factor using the adsorbate
JPH02195877A (en) * 1989-01-23 1990-08-02 Chemo Sero Therapeut Res Inst Purification of retro virus
WO1991013976A1 (en) * 1990-03-14 1991-09-19 Yamanouchi Pharmaceutical Co., Ltd. Process for producing purified tissue plasminogen activator or its derivative
GB2429708A (en) * 2005-09-01 2007-03-07 Chisso Corp Spherical sulphated cellulose
JP2008222604A (en) * 2007-03-09 2008-09-25 Chisso Corp Cosmetic compounding agent and cosmetic composition containing the same
GB2465301A (en) * 2005-09-01 2010-05-19 Chisso Corp Spherical sulphated cellulose
JP4751558B2 (en) * 2000-04-07 2011-08-17 一般財団法人化学及血清療法研究所 Japanese encephalitis inactivated vaccine and production method thereof
JP2020124680A (en) * 2019-02-05 2020-08-20 国立大学法人福井大学 Protein adsorbent and method for producing the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5332090B2 (en) * 2005-09-01 2013-11-06 Jnc株式会社 Spherical sulfated cellulose and method for producing the same

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63209750A (en) * 1987-02-25 1988-08-31 Kanegafuchi Chem Ind Co Ltd Adsorbent for purifying viii th blood coagulation factor and process for purifying said factor using the adsorbate
JPH02195877A (en) * 1989-01-23 1990-08-02 Chemo Sero Therapeut Res Inst Purification of retro virus
WO1991013976A1 (en) * 1990-03-14 1991-09-19 Yamanouchi Pharmaceutical Co., Ltd. Process for producing purified tissue plasminogen activator or its derivative
JP4751558B2 (en) * 2000-04-07 2011-08-17 一般財団法人化学及血清療法研究所 Japanese encephalitis inactivated vaccine and production method thereof
GB2429708A (en) * 2005-09-01 2007-03-07 Chisso Corp Spherical sulphated cellulose
GB2465301A (en) * 2005-09-01 2010-05-19 Chisso Corp Spherical sulphated cellulose
GB2429708B (en) * 2005-09-01 2010-06-02 Chisso Corp Spherical sulfated cellulose
GB2465301B (en) * 2005-09-01 2010-06-30 Chisso Corp Spherical sulfated cellulose
JP2008222604A (en) * 2007-03-09 2008-09-25 Chisso Corp Cosmetic compounding agent and cosmetic composition containing the same
JP2020124680A (en) * 2019-02-05 2020-08-20 国立大学法人福井大学 Protein adsorbent and method for producing the same

Also Published As

Publication number Publication date
JPH0423751B2 (en) 1992-04-23

Similar Documents

Publication Publication Date Title
KR920009733B1 (en) Method for purification of influenza virus
EP0208215B1 (en) Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
KR890001927B1 (en) Method for purification of filamentous hemagglutinin
KR880002586B1 (en) Method for purification of hepatitis b virus surface antigen
JPS6154450A (en) Gel for affinity chromatography having group specificity and its production
JPS6356501A (en) Cellulose gel having biochemical affinity and production thereof
KR920009730B1 (en) Method for the production of pertusiss component vaccine and combined vaccine of pertussis antigen diphtheria toxoid and tetanus toxoid
JPS6154451A (en) Gel for affinity chromatography having group specificity and its production
JP2573467B2 (en) Pharmaceutical compositions suitable for therapeutic use containing factor IX protein
WO1995011966A1 (en) Human activated protein c preparation and process for producing the same
EP0170162B1 (en) Method for the purification of leukocytosis-promoting factor haemagglutinin
JPH07508989A (en) Purification of factor 9
JP2722140B2 (en) Method for producing human urinary trypsin inhibitor
US20030148488A1 (en) Method for the production of pure virally inactivated butyrylcholinesterase
JPS6156133A (en) Removal of pyrogens
CS196349B2 (en) Process for preparing heparine
JPS6130528A (en) Method for purifying lpf-ha
JPS63146898A (en) Thrombin-linking substance and production thereof
JPH04365481A (en) Production of thrombin
JPS641446B2 (en)
JPS59164727A (en) Purification of surface antigen of hepatitis virus b
JPS641447B2 (en)
JPS60218326A (en) Purification of fibrous hemagglutinin
JPS5810522A (en) Purification of antithrombin 3 by deactivated thrombin gel
JPS5838150B2 (en) Kallikrein purification method

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term